These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11188912)

  • 1. [Beta inhibitors in the treatment of chronic cardiac insufficiency, are they useful in stable but severely ill patients?].
    Martínez Martínez JA
    Medicina (B Aires); 2000; 60(5 Pt 1):665. PubMed ID: 11188912
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-blocker in secondary prevention of cardiovascular disease].
    Sauer G
    Z Kardiol; 2003 Jan; 92(1):24-30. PubMed ID: 12545298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 4. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction.
    Fonarow GC
    Cardiol Clin; 2008 Feb; 26(1):79-89, vii. PubMed ID: 18312908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers in the treatment of aortic regurgitation a new opportunity?
    Elkayam U
    J Am Coll Cardiol; 2009 Jul; 54(5):458-9. PubMed ID: 19628122
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT; Greenberg BH; Yancy CW
    Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Roy P; Bouchard J; Amyot R; Madore F
    Am J Kidney Dis; 2006 Oct; 48(4):645-51. PubMed ID: 16997061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between usage of beta-blocking medication and benefit from implantable cardioverter therapy.
    Mäkikallio TH; Huikuri HV
    Am J Cardiol; 2006 Nov; 98(9):1245-7. PubMed ID: 17056339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
    Buckberg GD;
    Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.
    Fonarow GC; Abraham WT; Cannon CP; Gheorghiade M; Sackner-Bernstein JD; Udelson JE;
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S54-9. PubMed ID: 14584479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.